Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and brain metastases: results from the CheckMate 920 trial.Hamid Emamekhoo,Mark R. Olsen,Bradley Curtis Carthon,Alexandra Drakaki,Ivor John Percent,Ana M. Molina,Daniel C. Cho,Johanna C. Bendell,Lucio N. Gordan,Arash Rezazadeh Kalebasty,Daniel J. George,Thomas E. Hutson,Edward Arrowsmith,Joshua Zhang,Jesus Zoco,Jennifer L. Johansen, David Leung,Scott S. TykodiJOURNAL OF CLINICAL ONCOLOGY(2021)引用 6|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要